Articles related to NURSING

Dive into the essence of AANA’s updated guidelines for obstetric anesthesia and analgesia as we spotlight its focus on health equity and safety in maternal care. Commencing with the unveiling of the revised practice guidelines for obstetric anesthesia and analgesia, the American Association of Nurse Anesthesiology (AANA) has emphasized enhancing patient care and safety. Interestingly, these updates also strive to tackle the critical issue of enduring health disparities in the United States. The AANA firmly believes in the power of certified registered nurse anesthetists (CRNAs) to help curb maternal mortality rates. The primary strategy focuses on mitigating racial and ethnic imbalances in pregnancy-related deaths. Beth Ann Clayton, DNP, CRNA, FAANA, FAAN, the key subject matter expert behind the revisions, underscores these inequalities as significant barriers to optimal maternal care. Using an evidence-based process, the AANA revised the guidelines, paying careful attention to current research. They’ve prioritized enhancing the readability of the content, updating the quality of references, and broadening their scope to encompass the most recent recommendations on obstetric analgesia and anesthesia care. The notable alterations include the broadening of analgesia and anesthesia considerations for labor and delivery. This expansion encompasses inhalation analgesia, neuraxial analgesia, general anesthesia, and an updated […]

At the 2023 National Comprehensive Cancer Network (NCCN) Annual Conference, a panel of experts discussed solutions to address staff shortages and retain workers in cancer care. The suggestions ranged from offering work-from-home opportunities to gifting small gestures like cookies and wine, with the aim of improving employee retention. The value of flexible working options and compensation were recurring themes, along with the importance of employee recognition programs and discussing career advancement opportunities. Exacerbated by the pandemic, burnout, and early retirements, the shortage of nurses and doctors in cancer centers has become more pressing as Americans grow older and require more oncology services. The panelists emphasized that having visible management, offering flexible working options, and providing employee recognition programs are important steps to retain staff in cancer care. They also discussed the significance of discussing career advancement opportunities and avoiding the use of temporary travel staff to retain employees.

The author explains that a nursing strike can have a significant impact on oncology practices, which rely heavily on nursing staff for patient care. The article suggests that practices should have a contingency plan in place in the event of a strike, including identifying alternative sources of nursing staff, communicating with patients about the potential impact on their care, and ensuring that all staff members are trained on how to handle the situation. The article also emphasizes the importance of maintaining a respectful and open dialogue with nursing staff throughout the negotiation process to minimize the likelihood of a strike.

The US Bureau of Labor Statistics released job growth projections for the next decade, from 2021 to 2031. Nurse practitioners are expected to grow at a rate of 45% across all industries. Over the next ten years, the number of employed nurse practitioners is expected to increase from 246,700 to 359,400. Sadly, physicians are missing from the list, with the Association of American Medical Colleges projecting a shortage of 37,800 to 124,000 physicians by the year 2034.

Lack of Concordance Between Radiologic and Pathologic Responses in Neoadjuvant ICI Treatment of Melanoma: How Do I Assess Radiologic Progression? After taking part in this CME activity, medical oncologists, surgeons, dermatologists, oncology nurses, oncology pharmacists, and other members of the interprofessional team who manage patients with melanoma should be better able to:

Hematologist-oncologists, hematology-oncology NP/PAs, hematology-oncology nurses, and pharmacists should be better able to use criteria for erythroid-stimulating agent (ESA) failure to hasten the identification of patients with lower-risk myelodysplastic syndrome (MDS) refractory to ESA therapy, integrate safety and efficacy data on emerging therapeutic options into treatment planning for patients with lower-risk MDS after ESA failure, and integrate a multidisciplinary treatment approach after taking part in this CME activity.